Clinical Report: Distinct Serum Extracellular Vesicle Proteomic Profiles Characterize Hepatic Steatosis in Women After Menopause

Overview

This study identifies distinct serum extracellular vesicle (EV) proteomic profiles associated with hepatic steatosis in postmenopausal women. The findings suggest that these EVs may serve as potential biomarkers for early detection and understanding of metabolic dysfunction in this population.

Background

Postmenopausal women face increased risks of metabolic dysfunction-associated steatotic liver disease (MASLD) due to hormonal changes. With a rising prevalence of MASLD among women, understanding its mechanisms is crucial for developing targeted prevention and treatment strategies. Current diagnostic methods for liver health are limited, highlighting the need for novel biomarkers like extracellular vesicles (EVs).

Data Highlights

No numerical data provided in the source material.

Key Findings

• Postmenopausal women exhibit distinct serum EV proteomic profiles linked to hepatic steatosis.
• EV levels correlate positively with the severity of MASLD, suggesting their role in disease progression.
• Current clinical assessments for MASLD, such as ALT and AST levels, lack sensitivity and specificity.
• EVs may provide a more comprehensive molecular context for understanding metabolic dysfunction.
• Animal studies indicate that EVs from steatotic hepatocytes exacerbate liver injury and inflammation.

Clinical Implications

The identification of EVs as potential biomarkers for MASLD could enhance early detection and risk stratification in postmenopausal women. Clinicians should consider integrating EV profiling into routine assessments to better manage and treat hepatic dysfunction in this population.

Conclusion

The study underscores the importance of serum EV proteomic profiles in characterizing hepatic steatosis in postmenopausal women, paving the way for improved diagnostic and therapeutic approaches.

References

1. Endocrine Reviews, 2023 -- The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy
2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Long-Term Analysis of Plasma Metabolite Changes During Menopause and Their Links to Subsequent Development of Metabolic Syndrome
3. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Links Between Body Fat Types, 27-Hydroxycholesterol, and Sex Hormones: Insights from the Multiethnic Cohort Study
4. European Journal of Preventive Cardiology, 2023 -- Extracellular vesicle signature is associated with cardio-metabolic improvement after bariatric surgery
5. Burden of steatotic liver disease in postmenopausal women: NHANES 2017–2020 insights - PMC, 2023
6. Hepatology, 2025 -- Resmetirom therapy for metabolic.
7. Hepatic steatosis in postmenopausal women is characterized by distinct serum extracellular vesicle proteomic signatures | BMC Medicine | Springer Nature Link, 2025
8. Burden of steatotic liver disease in postmenopausal women: NHANES 2017–2020 insights - PMC
9. Hepatology
10. Hepatic steatosis in postmenopausal women is characterized by distinct serum extracellular vesicle proteomic signatures | BMC Medicine | Springer Nature Link